达安基因

- 002030

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
达安基因(002030) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入40,038.1419,830.77118,089.7184,233.6253,621.84
营业收入40,038.1419,830.77118,089.7184,233.6253,621.84
二、营业总成本45,431.2320,795.15113,344.0882,299.5355,421.07
营业成本23,534.978,758.1258,492.9138,071.6825,252.89
营业税金及附加278.69122.32978.17460.03285.32
销售费用6,299.582,541.9017,283.3313,565.3910,247.08
管理费用6,805.635,341.4413,831.3414,063.309,785.35
财务费用-3,378.17-1,608.76-7,474.89-6,133.33-5,340.38
研发费用11,890.535,640.1230,233.2222,272.4515,190.81
资产减值损失----------
公允价值变动收益-30,686.12-36,557.2943,569.0640,329.1647,996.02
投资收益-2,996.06-2,209.61-2,624.67-33.502,009.00
其中:对联营企业和合营企业的投资收益-4,514.40-2,586.42-4,610.08-1,359.72690.06
汇兑收益----------
三、营业利润-47,473.73-43,330.6912,162.1943,153.3948,910.02
加:营业外收入12.8412.65188.96153.49149.39
减:营业外支出140.6788.77997.55348.60328.21
其中:非流动资产处置损失----------
四、利润总额-47,601.56-43,406.8111,353.5942,958.2948,731.20
减:所得税费用-7,836.98-7,292.724,180.448,347.988,891.93
五、净利润-39,764.58-36,114.097,173.1634,610.3139,839.27
归属于母公司所有者的净利润-39,921.91-36,329.0610,465.9635,259.4440,275.54
少数股东损益157.32214.98-3,292.80-649.13-436.27
六、每股收益
基本每股收益(元/股)-0.2800-0.25890.07460.25120.2900
稀释每股收益(元/股)-0.2800-0.25890.07460.25120.2900
七、其他综合收益48.5122.05-86.7142.3340.09
八、综合收益总额-39,716.07-36,092.047,086.4534,652.6439,879.37
归属于母公司所有者的综合收益总额-39,877.40-36,306.7010,359.2435,284.2940,294.79
归属于少数股东的综合收益总额161.33214.67-3,272.79-631.65-415.43
下载全部历史数据到excel中 返回页顶